Pre-end-stage Renal Disease Visit-to-visit Systolic Blood Pressure Variability and Post-end-stage Renal Disease Mortality in Incident Dialysis Patients
Overview
Authors
Affiliations
Objectives: Higher SBP visit-to-visit variability (SBPV) has been associated with increased risk of adverse events in patients with chronic kidney disease, but the association of SBPV in advanced nondialysis-dependent chronic kidney disease with mortality after the transition to end-stage renal disease (ESRD) remains unknown.
Methods: Among 17 729 US veterans transitioning to dialysis between October 2007 and September 2011, we assessed SBPV calculated from the SD of at least three intraindividual outpatient SBP values during the last year prior to dialysis transition (prelude period). Outcomes included factors associated with higher prelude SBPV and post-transition all-cause, cardiovascular, and infection-related mortality, assessed using multivariable linear regression and Cox and competing risk regressions, respectively, adjusted for demographics, comorbidities, medications, cardiovascular medication adherence, SBP, BMI, estimated glomerular filtration rate, and type of vascular access.
Results: Modifiable clinical factors associated with higher prelude SBPV included higher SBP, use of antihypertensive medications and erythropoiesis-stimulating agents, inadequate cardiovascular medication adherence, and catheter use. After multivariable adjustment, higher prelude SBPV was significantly associated with higher post-ESRD all-cause and infection-related mortality, but not cardiovascular mortality [hazard/subhazard ratios (95% confidence interval) for the highest (vs. lowest) quartile of SBPV, 1.08 (1.01-1.16), 1.02 (0.89-1.15), and 1.41 (1.10-1.80) for all-cause, cardiovascular, and infection-related mortality, respectively].
Conclusion: High pre-ESRD SBPV is potentially modifiable and associated with higher all-cause and infection-related mortality following dialysis initiation. Further studies are needed to test whether modification of pre-ESRD SBPV can improve clinical outcomes in incident ESRD patients. VIDEO ABSTRACT:.
Xu S, Hao L, Liu F, Xu C Sleep Breath. 2024; 28(3):1251-1260.
PMID: 38326691 DOI: 10.1007/s11325-024-03005-4.
Ko S, Yang C, Sung P, Cheng B, Shao P, Chen Y Exp Biol Med (Maywood). 2023; 248(23):2421-2439.
PMID: 38059322 PMC: 10903247. DOI: 10.1177/15353702231198087.
Zhao Y, Yang L, Yu S, Salerno S, Li Y, Cui T Kidney Dis (Basel). 2021; 7(5):411-424.
PMID: 34604346 PMC: 8443949. DOI: 10.1159/000511295.
Association of dyskalemias with short-term health care utilization in patients with advanced CKD.
Dashputre A, Gatwood J, Sumida K, Thomas F, Akbilgic O, Potukuchi P J Manag Care Spec Pharm. 2021; 27(10):1403-1415.
PMID: 34595956 PMC: 10119640. DOI: 10.18553/jmcp.2021.27.10.1403.
Predialysis Potassium Variability and Postdialysis Mortality in Patients With Advanced CKD.
Dashputre A, Potukuchi P, Sumida K, Kar S, Obi Y, Thomas F Kidney Int Rep. 2021; 6(2):366-380.
PMID: 33615062 PMC: 7879127. DOI: 10.1016/j.ekir.2020.11.022.